Premarket Mover: Galmed Pharmaceuticals Ltd (GLMD) Down 2.07%

Galmed Pharmaceuticals Ltd (GLMD) has fallen Monday morning, with the stock decreasing -2.07% in pre-market trading to 1.42. GLMD's short-term technical score of 9 indicates that the stock has traded less bullishly over the last month than 91% of stocks on the market. In the Biotechnology industry, which ranks 124 out of 146 industries, the stock ranks higher than 17% of stocks. Galmed Pharmaceuticals Ltd has fallen 59.72% over the past month, closing at $3.44 on June 19. During this period of time, the stock fell as low as $1.45 and as high as $5.47. GLMD has an average analyst recommendation of Sell. The company has an average price target of $14.99.

GLMD has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on GLMD!

See Full GLMD Report

Galmed Pharmaceuticals Ltd has a Long-Term Technical rank of 17. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 83% of the market scoring higher. In the Biotechnology industry which is number 122 by this metric, GLMD ranks better than 122% of stocks.

Important Dates for Investors in GLMD:

-Galmed Pharmaceuticals Ltd is set to release earnings on 8/3/2023. Over the last 12 months, the company has reported EPS of $0.71. -We do not have a set dividend date for Galmed Pharmaceuticals Ltd at this time. Click Here To Get The Full Report on Galmed Pharmaceuticals Ltd (GLMD)